| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
Was ist ein ATC-Code? | Zur ATC-Übersicht |
|
L | | FI | PI | | Zovirax 200 mg - T | 25 Tablette(n) | 12.74 | 30.15 | 10% | | Filmtabletten (suspendierbar): Aciclovirum 200 mg | GlaxoSmithKline AG | A / SL / SO | FB | | G |  |
L | | FI | PI | | Acyclovir-Mepha 200 | 25 Tablette(n) | 10.83 | 28.20 | 10% | | Tabletten: Aciclovirum 200 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Acyclovir-Mepha 400 ‐ F | 30 Tablette(n) | 21.31 | 39.60 | 10% | | Tabletten: Aciclovirum 400 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Acyclovir-Mepha 400 ‐ F | 70 Tablette(n) | 47.58 | 68.15 | 10% | | Tabletten: Aciclovirum 400 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Acyclovir-Mepha 800 | 35 Tablette(n) | 42.35 | 62.45 | 10% | | Tabletten: Aciclovirum 800 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Zovirax | 100 ml | 26.18 | 44.90 | 10% | | Suspension: Aciclovirum 400mg / 5ml | GlaxoSmithKline AG | A / SL | FB | | G |  |
| | FI | | | Zovirax i.v. | 5 Ampulle(n) | PA | PA | k.A. | | Lyophilisat: Aciclovirum 250 mg | GlaxoSmithKline AG | A | FB | | G |  |
| | FI | | | Aciclovir Labatec | 5 Durchstechflasche(n) | PA | PA | k.A. | | Trockensubstanz: Aciclovirum 250 mg | Labatec Pharma SA | A | FB | | G |  |
|
| | FI | PI | | Cymevene | Ampulle(n) | 47.75 | 68.35 | 10% | | Pulver für ein Konzentrat zur Herstellung einer Infusionslösung: Ganciclovirum 500 mg | Cheplapharm Schweiz GmbH | A / SL | FB | | G |  |
| | FI | PI | | Cymevene 250 mg | 84 Kapsel(n) | PA | PA | k.A. | | Kapseln: Ganciclovirum 250 mg | Roche Pharma (Schweiz) AG | A | FB | | G |  |
| | FI | PI | | Cymevene 500 mg | 90 Kapsel(n) | PA | 1570.45 | k.A. | | Kapseln: Ganciclovirum 500 mg | Roche Pharma (Schweiz) AG | A | FB | | G |  |
|
| | FI | PI | | Famvir 125 mg | 10 Tablette(n) | 21.95 | 40.30 | 10% | | Filmtabletten: Famciclovirum 125 mg | Atnahs Pharma Switzerland AG | A / SL | FB | | G |  |
| | FI | PI | | Famvir 250 mg - T | 15 Tablette(n) | 60.74 | 82.45 | 10% | | Filmtabletten: Famciclovirum 250 mg | Atnahs Pharma Switzerland AG | A / SL | FB | | G |  |
| | FI | PI | | Famvir 500 mg | 14 Tablette(n) | 103.21 | 128.65 | 10% | | Filmtabletten: Famciclovirum 500 mg | Atnahs Pharma Switzerland AG | A / SL | FB | | G |  |
| | FI | PI | | Famvir 500 mg | 21 Tablette(n) | 141.01 | 169.75 | 10% | | Filmtabletten: Famciclovirum 500 mg | Atnahs Pharma Switzerland AG | A / SL | FB | | G |  |
| | FI | PI | | Famvir 500 mg | 30 Tablette(n) | 210.71 | 245.60 | 10% | | Filmtabletten: Famciclovirum 500 mg | Atnahs Pharma Switzerland AG | A / SL | FB | | G |  |
|
| | FI | | | Sidovis | | PA | PA | k.A. | | Infusionskonzentrat: Cidofovirum 75 mg/ml | Ideogen AG | A | FB | | G |  |
| | FI | | | Vistide | Ampulle(n) | 980.30 | 1136.65 | k.A. | | Infusionskonzentrat: Cidofovirum 375mg / 5ml | Gilead Sciences Switzerland Sàrl | A | FB | | G |  |
|
| | FI | PI | | Valcyte | 60 Tablette(n) | 1159.41 | 1270.85 | 10% | | Filmtabletten: Valganciclovirum 450 mg | Cheplapharm Schweiz GmbH | ● A / SL / SO | FB | | G |  |
| | FI | PI | | Valganciclovir Sandoz 450 mg | 60 Tablette(n) | 1054.01 | 1162.70 | 10% | | Filmtabletten: Valganciclovirum 450 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Valganciclovir-Mepha 450 | 60 Tablette(n) | 1054.01 | 1162.70 | 10% | | Filmtabletten: Valganciclovirum 450 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
|
| | FI | PI | | Brivex | 7 Tablette(n) | 60.90 | 82.65 | 10% | | Tabletten: Brivudinum 125 mg | A. Menarini GmbH | A / SL | FB | | G |  |
|
| | FI | | | Foscarnet Ideogen 24 mg/ml | | PA | PA | k.A. | | Infusionslösung: Foscarnetum Natricum Hexahydricum 24 mg/ml | Ideogen AG | A | FB | | G |  |
| | FI | | | Foscavir | 250 ml | PA | PA | k.A. | | Infusionslösung: Foscarnetum Natricum Hexahydricum 24 mg/ml | Curatis AG | A | FB | | G |  |
|
| | FI | | | Atazanavir-Mepha 200mg | 60 | 353.72 | 401.10 | 10% | | Kapseln: Atazanavirum 200 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | | | Atazanavir-Mepha 300mg | 30 | 353.72 | 401.10 | 10% | | Kapseln: Atazanavirum 300 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Atazanavir-Mepha 150mg | 60 | PA | PA | k.A. | | Kapseln: Atazanavirum 150 mg | Mepha Pharma AG | A | FB | | G |  |
|
| | FI | PI | | Darunavir Viatris 400 mg | 60 | 213.57 | 249.15 | 10% | | Tabletten: Darunavirum 400 mg | Viatris Pharma GmbH | A / SL / SG | FB | | G |  |
| | FI | | | Darunavir Viatris 600 mg | 60 | 320.37 | 365.50 | 10% | | Tabletten: Darunavirum 600 mg | Viatris Pharma GmbH | ● A / SL / SG | FB | | G |  |
| | FI | | | Darunavir Viatris 800 mg | 30 | 213.57 | 249.10 | 10% | | Tabletten: Darunavirum 800 mg | Viatris Pharma GmbH | A / SL / SG | FB | | G |  |
| | FI | PI | | Prezista 600 mg | 60 Tablette(n) | 634.72 | 688.00 | 40% | | Filmtabletten: Darunavirum 600 mg | Janssen-Cilag AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Prezista 800 mg | 30 Tablette(n) | 423.15 | 464.15 | 40% | | Filmtabletten: Darunavirum 800 mg | Janssen-Cilag AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Darunavir Sandoz 400 mg | 60 | 234.92 | 271.10 | 10% | | Filmtabletten: Darunavirum 400 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Darunavir Sandoz 600 mg | 60 | 352.40 | 398.35 | 10% | | Filmtabletten: Darunavirum 600 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | | | Darunavir Sandoz 800 mg | 30 | 234.92 | 271.05 | 10% | | Filmtabletten: Darunavirum 800 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Darunavir Sandoz 400 mg | 60 | PA | PA | k.A. | | Filmtabletten: Darunavirum 400 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Darunavir Sandoz 600 mg | 60 | PA | PA | k.A. | | Filmtabletten: Darunavirum 600 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | | | Darunavir Sandoz 800 mg | 30 | PA | PA | k.A. | | Filmtabletten: Darunavirum 800 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | PI | | Prezista 100 mg/ml | Flasche(n) | PA | PA | k.A. | | Suspension (oral): Darunavirum 100 mg/ml | Janssen-Cilag AG | A | FB | | G |  |
|
| | FI | PI | | Lamivudin-Mepha 150 | 60 | 141.05 | 169.80 | 10% | | Filmtabletten: Lamivudinum 150 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Lamivudin-Mepha 300 | 30 | 141.05 | 169.80 | 10% | | Filmtabletten: Lamivudinum 300 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Zeffix - T | 28 Tablette(n) | 70.63 | 93.25 | 10% | | Filmtabletten: Lamivudinum 100 mg | GlaxoSmithKline AG | A / SL | FB | | G |  |
L | | FI | PI | | Zeffix - T | 84 Tablette(n) | 182.15 | 214.50 | 10% | | Filmtabletten: Lamivudinum 100 mg | GlaxoSmithKline AG | A / SL | FB | | G |  |
L | | FI | PI | | Zeffix | 240 ml | 27.75 | 46.60 | 10% | | Lösung (oral): Lamivudinum 5 mg/ml | GlaxoSmithKline AG | A / SL | FB | | G |  |
| | FI | PI | | 3TC 150 mg | 60 Tablette(n) | 164.55 | 193.95 | 10% | | Filmtabletten: Lamivudinum 150 mg | ViiV Healthcare GmbH | A / SO | FB | | G |  |
| | FI | PI | | 3TC 300 mg | 30 Tablette(n) | 164.55 | 193.95 | 10% | | Filmtabletten: Lamivudinum 300 mg | ViiV Healthcare GmbH | A / SO | FB | | G |  |
| | FI | PI | | 3TC | 240 ml | 50.73 | 71.60 | 10% | | Lösung oral: Lamivudinum 10 mg/ml | ViiV Healthcare GmbH | A | FB | | G |  |
|
| | FI | PI | | Ziagen - T | 60 Tablette(n) | 228.64 | 265.10 | 10% | | Filmtabletten: Abacavirum 300 mg | ViiV Healthcare GmbH | A / SL | FB | | G |  |
| | FI | PI | | Ziagen | 240 ml | 66.97 | 89.25 | 10% | | Lösung (oral): Abacavirum 20 mg/ml | ViiV Healthcare GmbH | A / SL | FB | | G |  |
|
| KFI | FI | PI | | Emtriva | 30 Kapsel(n) | 203.88 | 238.15 | 10% | | Kapseln: Emtricitabinum 200 mg | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
|
| | FI | PI | | Baraclude 0.5 mg | 30 Tablette(n) | 390.55 | 439.00 | 10% | | Filmtabletten: Entecavirum | Bristol-Myers Squibb SA | A / SL / SO | FB | | G |  |
| | FI | PI | | Baraclude 0.5 mg | 30 | 335.33 | 382.30 | 10% | | Filmtabletten: Entecavirum | APS-Arzneimittel- Parallelimport- Service AG | A / SL / SO | FB | | G |  |
L | | FI | PI | | Baraclude 1 mg | 30 Tablette(n) | 493.15 | 550.00 | 10% | | Filmtabletten: Entecavirum 1 mg | Bristol-Myers Squibb SA | A / SL / SO | FB | | G |  |
L | | FI | | | Baraclude 1 mg | 30 | 465.74 | 521.85 | 10% | | Filmtabletten: Entecavirum 1 mg | APS-Arzneimittel- Parallelimport- Service AG | A / SL / SO | FB | | G |  |
| | FI | PI | | Entecavir Sandoz 0.5 mg | 30 + 30 + 30 + 30 + 30 | 355.06 | 402.55 | 10% | | Filmtabletten: Entecavirum | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
L | | FI | PI | | Entecavir Sandoz 1 mg | 30 + 30 + 30 + 30 + 30 | 448.32 | 504.00 | 10% | | Filmtabletten: Entecavirum 1 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Entecavir-Mepha 0.5mg | 30 | 355.06 | 402.55 | 10% | | Filmtabletten: Entecavirum | Mepha Pharma AG | A / SL / SG | FB | | G |  |
L | | FI | | | Entecavir-Mepha 1.0mg | 30 | 448.32 | 504.00 | 10% | | Filmtabletten: Entecavirum 1 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Baraclude 0.5 mg | 30 | PA | PA | k.A. | | Filmtabletten: Entecavirum | APS-Arzneimittel- Parallelimport- Service AG | A | FB | | G |  |
| | FI | PI | | Baraclude 0.5 mg | 30 | PA | PA | k.A. | | Filmtabletten: Entecavirum | APS-Arzneimittel- Parallelimport- Service AG | A | FB | | G |  |
| | FI | | | Baraclude 1 mg | 30 | PA | PA | k.A. | | Filmtabletten: Entecavirum 1 mg | APS-Arzneimittel- Parallelimport- Service AG | A | FB | | G |  |
| | FI | | | Baraclude 1 mg | 30 | PA | PA | k.A. | | Filmtabletten: Entecavirum 1 mg | APS-Arzneimittel- Parallelimport- Service AG | A | FB | | G |  |
| | FI | PI | | Entecavir Sandoz 0.5 mg | 30 | PA | PA | k.A. | | Filmtabletten: Entecavirum | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | PI | | Entecavir Sandoz 1 mg | 30 | PA | PA | k.A. | | Filmtabletten: Entecavirum 1 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | FI | PI | | Baraclude 0.05 mg/mL | 210 ml | PA | PA | k.A. | | Lösung (oral): Entecavirum | Bristol-Myers Squibb SA | A | FB | | G |  |
|
| | FI | PI | | Efavirenz-Mepha 600 mg | 30 Tablette(n) | 211.41 | 246.35 | 10% | | Filmtabletten: Efavirenzum 600 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
|
L | KFI | FI | PI | | Intelence 200 mg | 60 Tablette(n) | 379.61 | 429.25 | 10% | | Tabletten: Etravirinum 200 mg | Janssen-Cilag AG | A / SL | FB | | G |  |
|
| | FI | PI | | Pifeltro | 30 | 409.79 | 462.10 | 10% | | Filmtabletten: Doravirinum 100 mg | MSD Merck Sharp & Dohme AG | A / SL | FB | | G |  |
|
L | | FI | PI | | Vocabria 30 mg | 30 | 599.80 | 668.75 | 10% | | Filmtabletten: Cabotegravirum 30 mg | ViiV Healthcare GmbH | A / SL | FB | | G |  |
L | | FI | | | Vocabria 600 mg / 3 ml | | 1248.14 | 1373.85 | 10% | | Depot-Injektionssuspension: Cabotegravirum 600mg / 3ml | ViiV Healthcare GmbH | A / SL | FB | | G |  |
| | FI | | | Vocabria 400 mg / 2 ml | | PA | PA | k.A. | | Depot-Injektionssuspension: Cabotegravirum 400mg / 2ml | ViiV Healthcare GmbH | A | FB | | G |  |
|
L | | FI | PI | PS | Maviret Filmtabletten | 84 | 14407.03 | 15089.40 | 10% | | 2 Wirkstoffe | AbbVie AG | A / SL | FB | | G |  |
|
| | FI | PI | | Kivexa | 30 Tablette(n) | 273.20 | 312.00 | 10% | | Filmtabletten: 2 Wirkstoffe | ViiV Healthcare GmbH | A / SL / SO | FB | | G |  |
| | FI | PI | | Abacavir Lamivudin Sandoz | 30 | 248.42 | 286.60 | 10% | | Filmtabletten: 2 Wirkstoffe | Sandoz Pharmaceuticals AG | A / SG | FB | | G |  |
| | FI | PI | | Abacavir-Lamivudin-Mepha 600 mg/300 mg | 30 | 248.42 | 286.60 | 10% | | Filmtabletten: 2 Wirkstoffe | Mepha Pharma AG | A / SG | FB | | G |  |
| | FI | PI | | Kivexa 600 mg / 300 mg | 30 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | A | FB | | G |  |
| | FI | PI | | Kivexa 600 mg / 300 mg | 30 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | A | FB | | G |  |
| | FI | PI | | Kivexa 600mg/300 mg | 30 | PA | PA | k.A. | | Filmtabletten: 2 Wirkstoffe | APS-Arzneimittel- Parallelimport- Service AG | A | FB | | G |  |
|
| | FI | | | Efavirenz/Emtricitabin/Tenofovir Viatris | 30 | 526.02 | 588.50 | 10% | | Mylan: 3 Wirkstoffe | Viatris Pharma GmbH | ● A / SL / SG | FB | | G |  |
| | FI | PI | | Efavirenz-Emtricitabin- Tenofovir-Mepha 600 mg, 200 mg | 30 | 526.02 | 588.50 | 10% | | mg: 3 Wirkstoffe | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | FI | PI | | Efavirenz/Emtricitabin/Tenofovir Viatris | 30 | 526.02 | 588.50 | k.A. | | Mylan: 3 Wirkstoffe | Viatris Pharma GmbH | A | FB | | G |  |
| | FI | PI | | Efavirenz-Emtricitabin- Tenofovir-Mepha 600 mg, 200 mg | 3 x 30 | PA | PA | k.A. | | mg: 3 Wirkstoffe | Mepha Pharma AG | A | FB | | G |  |
|
| | FI | PI | PS | Eviplera | 30 Tablette(n) | 780.92 | 865.70 | 10% | | Filmtabletten: 3 Wirkstoffe | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
|
| | FI | PI | | Descovy 200/10 mg | 30 | 612.80 | 682.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
| | FI | PI | | Descovy 200/25 mg | 30 | 612.80 | 682.85 | 10% | | Filmtabletten: 2 Wirkstoffe | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
|
| | FI | PI | PS | Genvoya 150mg/150mg/200mg/10mg | 30 | 1070.40 | 1180.55 | 10% | | Filmtabletten: 4 Wirkstoffe | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
|
| | FI | PI | | Odefsey 200/25/25 mg | 30 | 834.37 | 923.85 | 10% | | Filmtabletten: 3 Wirkstoffe | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
|
| | FI | PI | | Biktarvy | 30 | 1005.60 | 1110.05 | 10% | | Filmtabletten: 3 Wirkstoffe | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
| | FI | PI | | Biktarvy | 30 | 1005.60 | 1110.05 | 10% | | Filmtabletten: 3 Wirkstoffe | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
|
| | FI | PI | | Juluca 50 mg | 30 | 855.65 | 947.00 | 10% | | Filmtabletten: 2 Wirkstoffe | ViiV Healthcare GmbH | A / SL | FB | | G |  |
|
| | FI | PI | | Symtuza | 30 | 919.61 | 1016.55 | 10% | | Filmtabletten: 4 Wirkstoffe | Janssen-Cilag AG | A / SL | FB | | G |  |
|
| | FI | PI | | Dovato | 30 | 740.69 | 821.95 | 10% | | Filmtabletten: 2 Wirkstoffe | ViiV Healthcare GmbH | A / SL | FB | | G |  |
| | FI | PI | | Dovato | 30 | 740.69 | 821.95 | 10% | | Filmtabletten: 2 Wirkstoffe | ViiV Healthcare GmbH | A / SL | FB | | G |  |
|
| | FI | PI | | Xofluza 20 mg | 2 | PA | PA | k.A. | | Filmtabletten: Baloxavirum Marboxilum 20 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | PI | | Xofluza 20 mg | 4 | PA | PA | k.A. | | Filmtabletten: Baloxavirum Marboxilum 20 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | | | Xofluza 40 mg | | PA | PA | k.A. | | Filmtabletten: Baloxavirum Marboxilum 40 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | | | Xofluza 40 mg | 2 | PA | PA | k.A. | | Filmtabletten: Baloxavirum Marboxilum 40 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | | | Xofluza 80 mg | | PA | PA | k.A. | | Filmtabletten: Baloxavirum Marboxilum 80 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
| | FI | PI | | Xofluza 2 mg / ml | | PA | PA | k.A. | | Granulat zur Herstellung einer Suspension zum Einnehmen: Baloxavirum Marboxilum 40 mg | Roche Pharma (Schweiz) AG | B | FB | | G |  |
|
L | | FI | PI | | Hepcludex 2 mg | 30 | 5449.37 | 5898.85 | 10% | | Trockensubstanz: Bulevirtidum 2 mg | Gilead Sciences Switzerland Sàrl | A / SL | FB | | G |  |
|
| | FI | PI | | Rukobia 600 mg | 60 | PA | PA | k.A. | | Retard-Tabletten: Fostemsavirum 600 mg | ViiV Healthcare GmbH | A | FB | | G |  |